Smith Anderson advised Fortrea on the deal.Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO) that helps make life changing therapies for patients, has finalized…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
